Global Custom Market Research Reports Provider Company

phone

Vical Inc (VICL) - Financial and Strategic SWOT Analysis Review

  • Published Date: 05 Jul 2018
  • Number of Pages: 41
  • Category: SWOT Analysis
  • Country: United States of America
Vical Inc (VICL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Vical Inc (Vical) is a biopharmaceutical company, which focuses on research and development on DNA delivery technologies for the prevention and treatment of life-threatening diseases and vaccines for infectious diseases and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. Vaxfectin adjuvant is a proprietary cationic lipid-based formulation it is a protein--based vaccines. The companys DNA delivery technology takes up polynucleotide genetic material, such as DNA or RNA. The company has collaborations with major pharmaceutical companies and biotechnology companies that give it access to complementary technologies or greater resources. Vical is headquartered in San Diego, California, the US.

Vical Inc Key Recent Developments

May 03,2018: Vical Reports First Quarter 2018 Financial and Operational Results
Mar 15,2018: Vical Reports Fourth Quarter 2017 Financial and Operational Results
Jan 29,2018: Motif Bio, Spero Therapeutics and Vical Join Antimicrobials Working Group
Oct 23,2017: Vical Reports Third Quarter 2017 Financial and Operational Results
Aug 08,2017: Vical Reports Second Quarter 2017 Financial and Operational Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
Publisher Name : GlobalData


List of Tables 4
List of Figures 4
Section 1 - About the Company 5
Vical Inc - Key Facts 5
Vical Inc - Key Employees 6
Vical Inc - Key Employee Biographies 7
Vical Inc - Major Products and Services 8
Vical Inc - History 9
Vical Inc - Company Statement 12
Vical Inc - Locations And Subsidiaries 13
Head Office 13
Section 2 Company Analysis 14
Company Overview 14
Vical Inc - Business Description 15
Vical Inc - SWOT Analysis 16
SWOT Analysis - Overview 16
Vical Inc - Strengths 16
Vical Inc - Weaknesses 17
Vical Inc - Opportunities 18
Vical Inc - Threats 19
Vical Inc - Key Competitors 20
Section 3 Company Financial Ratios 21
Financial Ratios - Capital Market Ratios 21
Financial Ratios - Annual Ratios 22
Performance Chart 24
Financial Performance 24
Financial Ratios - Interim Ratios 25
Financial Ratios - Ratio Charts 26
Section 4 Companys Lifesciences Financial Deals and Alliances 27
Vical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
Vical Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28
Vical Inc, Recent Deals Summary 29
Section 5 Companys Recent Developments 30
May 03, 2018: Vical Reports First Quarter 2018 Financial and Operational Results 30
Mar 15, 2018: Vical Reports Fourth Quarter 2017 Financial and Operational Results 31
Jan 29, 2018: Motif Bio, Spero Therapeutics and Vical Join Antimicrobials Working Group 32
Oct 23, 2017: Vical Reports Third Quarter 2017 Financial and Operational Results 33
Aug 08, 2017: Vical Reports Second Quarter 2017 Financial and Operational Results 34
May 15, 2017: Vical Reports First Quarter 2017 Financial Results 35
Mar 09, 2017: Vical Reports Fourth Quarter 2016 Financial Results 36
Section 6 Appendix 37
Methodology 37
Ratio Definitions 37
About GlobalData 41
Contact Us 41
Disclaimer 41

List Of Tables

List of Tables
Vical Inc, Key Facts 5
Vical Inc, Key Employees 6
Vical Inc, Key Employee Biographies 7
Vical Inc, Major Products and Services 8
Vical Inc, History 9
Vical Inc, Key Competitors 20
Vical Inc, Ratios based on current share price 21
Vical Inc, Annual Ratios 22
Vical Inc, Annual Ratios (Cont...1) 23
Vical Inc, Interim Ratios 25
Vical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
Vical Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28
Vical Inc, Recent Deals Summary 29
Currency Codes 37
Capital Market Ratios 37
Equity Ratios 38
Profitability Ratios 38
Cost Ratios 39
Liquidity Ratios 39
Leverage Ratios 40
Efficiency Ratios 40

List Of Figures

List of Figures
Vical Inc, Performance Chart (2013 - 2017) 24
Vical Inc, Ratio Charts 26
Vical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
Vical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 28

Royal Mail plc (RMG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by

View Report

Leclanche SA (LECN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData

View Report

NEC Corp (6701) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports